iMediSync debuts iSyncWave, a dedicated device for neuropsychiatric disorders, at CES 2021
ALL DIGITAL, Dec 23, 2020/ iMediSync, a biotech startup developing an AI-driven early detection and therapeutic platform for optimal brain health. iMediSync will showcase a groundbreaking EEG (electroencephalogram) brain mapping and LED-therapeutic device, iSyncWave™ at CES (Consumer Electronics Show) 2021.
iSyncWave™ is a gel-free, portable EEG brain mapping device with LED photo-biomodulators. The device is especially designed for the early detection and supportive care of neuropsychiatric disorders such as dementia, Parkinson’s disease, TBI, PTSD, ADHD, depression, etc. iSyncWave™ will help neuropsychiatric patients to treat their illnesses at both clinics and homes. It will also allow for individuals to facilitate regular checkups to prevent degenerative neurological disorders.Continue Reading
- iSyncWave – The Future of Telemental Care
iMediSync’s Vision for Virtual Mental Care
A Message from SeungWan Kang MD Ph.D, a founder and CEO of iMediSync., Inc.
iSyncWave™ works with iSyncMe® – a mobile application that connects to iMediSync’s cloud platform, iSyncBrain®, the AI-driven EEG analysis platform for precision mental care. iSyncMe® also works as a telemedicine platform connecting iSyncWave™’s user to online doctors or mental care specialists.
iMediSync has completed a basic framework for their virtual care platform by adding iSyncWave™ and iSyncMe® to their product line. An easy and time-saving EEG brain mapping and LED therapy device can be used not only in clinics but also at homes by individuals. This will enable healthcare providers to monitor their patients remotely, providing constant care that can be delivered at home.
SeungWan Kang MD Ph.D, founder and CEO of iMediSync said “iSyncWave™ was created to provide an integrated service for both healthcare providers and individuals who want to understand their brain health with our comprehensive EEG analysis solution. At CES 2021, we look forward to meeting strategic partners who will pioneer the global market with iMediSync.”
Visit www.imedisync.com for more information.
About CES
CES® is the most influential tech event in the world —proving the ground for breakthrough technologies and global innovators. This is where the world’s biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA)®, CES features every aspect of the tech sector.
About iSyncWave™
iSyncWave™ provides AI-driven cloud based EEG (electroencephalogram) brain mapping and personalized LED therapeutics. Especially, iSyncWave™ uses dry sensors and doesn’t need gel paste as conventional EEG devices do. It also provides personalized LED therapeutics called photobiomodulation (PBM) according to the brain mapping results; as it can also be paired with iSyncMe® – mobile app, it will add a feature to connect patients and doctors virtually in the near future.
About iMediSync
iMediSync (www.imedisync.com) has developed an AI-driven early detection and therapeutic platform for optimal brain health, iSyncBrain®. iMediSync launched its first solution to detect amnestic Mild Cognitive Impairment or aMCI (early stage of Alzheimer’s Disease) based on its proprietary EEG database in Korea last August 2020 (iSyncBrain MCI Classifier – KFDA Cleared). They conducted the clinical trial with multicenter hospitals with results of 90%+ accuracy for its solution. The vision of iMediSync, just like iSyncBrain® MCI Classifier, is to develop early detecting biomarkers for challenging neurological disorders such as Parkinson’s disease, TBI, PTSD, ADHD, Depression etc.
